Landogrozumab ( 兰洛珠单抗 )
- 发布日期： 2020-10-22
- 更新日期： 2025-10-24
产品详请
| 产地 |
中国
|
| 品牌 |
Chemstan
|
| 货号 |
CSD00411
|
| 保存条件 |
store at -80℃
|
| 用途 |
仅用于科研用途
|
| 应用范围 |
|
| 抗原来源 |
CHO cells
|
| CAS编号 |
1391726-30-9
|
| 保质期 |
一年
|
| 抗体名 |
Landogrozumab ( 兰洛珠单抗 )
|
| 是否单克隆 |
|
| 克隆性 |
|
| 靶点 |
MSTN/GDF8[Homo sapiens]
|
| 适应物种 |
|
| 形态 |
|
| 宿主 |
|
| 标记物 |
|
| 包装规格 |
1mg/ml
|
| 纯度 |
%
|
| 亚型 |
|
| 标识物 |
|
| 浓度 |
95%
|
| 免疫原 |
|
| 是否进口 |
否
|
Landogrozumab has been used in trials studying the treatment of Advanced Cancer, Muscular Atrophy, and Pancreatic Cancer.
货号（Catalog No.）
CSD00411
通用名INN
Landogrozumab
纯度(Purity)
>95%
浓度( Concentration)
1mg/ml
Formulation
PBS buffer pH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
产品描述(Description)
Landogrozumab has been used in trials studying the treatment of Advanced Cancer, Muscular Atrophy, and Pancreatic Cancer.
别名(Alternative names)
LY-2495655
靶点;物种(Specificity target name;species)
MSTN/GDF8[Homo sapiens]
种类(Species)
Humanized
受体鉴定(Receptor identification)
IgG4-kappa
Note
For research use only. Not suitable for clinical or therapeutic use.
